Linezolid Altan

Linezolid, the active ingredient in Linezolid Altan, is a oxazolidinone antibiotic presented as an intravenous formulation for injection use. It treats serious Gram‑positive bacterial infections, including those caused by methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients requiring hospital care.

GNH USA supplies Linezolid Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to manage infections caused by resistant Gram‑positive bacteria. - Complicated skin and soft tissue infections: provides bacterial eradication and clinical improvement. - Community‑acquired bacterial pneumonia: reduces pathogen load and accelerates recovery. - Nosocomial pneumonia: effective against hospital‑acquired resistant strains. - Infections caused by methicillin‑resistant Staphylococcus aureus (MRSA): achieves rapid bacterial clearance. - Infections caused by vancomycin‑resistant Enterococcus (VRE): offers a therapeutic option where alternatives fail.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring during therapy. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve damage causing tingling or numbness. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Lactic acidosis: buildup of lactate leading to metabolic disturbance. - Optic neuropathy: vision changes requiring immediate evaluation.

Before initiating Linezolid therapy, consider the following safety measures. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid to prevent serotonin syndrome. - Bone marrow suppression: perform routine complete blood counts. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Linezolid can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Rifampin: may reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for enhanced bleeding. - Carbamazepine and other anticonvulsants: may lower linezolid effectiveness.